Clinical Trial Update: Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS) [Phase 1]

View source ↗

Summary

This entry notes a Phase 1 clinical trial evaluating intravenous immunoglobulin with blood-brain barrier disruption for amyotrophic lateral sclerosis. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Amyotrophic Lateral Sclerosis, ALS | Phase 1 | Status: RECRUITING